FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-106591.
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.08-106591v1
23/2/605    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolego, C.
Right arrow Articles by Sala, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolego, C.
Right arrow Articles by Sala, A.
(The FASEB Journal. 2009;23:605-612.)
© 2009 FASEB

Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone

Chiara Bolego*,1, Carola Buccellati*, Alberto Prada{dagger}, Rosa Maria Gaion{ddagger}, Giancarlo Folco* and Angelo Sala*,2

* Department of Pharmacological Sciences, University of Milan, Milan, Italy;

{dagger} Rho Hospital, Rho, Italy; and

{ddagger} Department of Pharmacology and Anesthesiology, University of Padova, Padova, Italy

2Correspondence: Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. E-mail: angelo.sala{at}unimi.it

We aimed at evaluating the relative contribution of cyclooxygenase (COX) -1 and COX-2 to the synthesis of prostacyclin in endothelial cells under static conditions in the presence or absence of exogenous arachidonic acid and/or altered intracellular redox balance. Selective inhibitors of either COX-1 (SC560 and FR122047) or COX-2 (SC236) concentration dependently (1–300 nM) reduced basal and interleukin (IL) -1β-induced prostacyclin production in human umbilical vein endothelial cells by 70% or more; compound selectivity was confirmed using a whole-blood assay (IC50 COX-1/COX-2: 13 nM/930 nM for SC-560; 9 µM/457 nM for SC-236). The observed concomitant formation of isoprostane appeared to be associated with COX enzyme activity, while formation of COX-1/COX-2 heterodimers was detected by immunoprecipitation. In the presence of arachidonic acid and 12-hydroperoxy-eicosatetraenoic acid, either exogenous or provided by platelet activation, or after glutathione depletion, COX-1 inhibition but not COX-2 inhibition concentration dependently decreased prostacyclin production. Both isoforms appear to contribute to basal prostacyclin production by endothelial cells, with COX-2 providing the hydroperoxide tone required for COX-1 activity. Conversely, in the case of intracellular glutathione depletion or enhanced availability of arachidonic acid and hydroperoxides, selective COX-2 inhibition did not significantly affect the production of endothelial prostacyclin. These findings contribute to a better understanding of the effects of cyclooxygenase inhibitors on prostacyclin production.—Bolego, C., Buccellati, C., Prada, A., Gaion, R. M., Folco, G., Sala, A. Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone.


Key Words: selective cyclooxygenase inhibitors • prostaglandin • isoprostanes • COX-2 heterodimers • 12-HpETE







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.